IHMA supports all phases of anti-infective therapy development, from discovery through commercialisation. We are your essential resource for central, reference, and clinical research laboratory services worldwide. 

  IHMA supports companies needing: 

• Pre-clinical studies for regulatory filings 
• Global laboratory services for all phases of clinical trials 
• Antimicrobial resistance (AMR) surveillance (bacterial and fungal) 
• Molecular characterisation and detection of infectious agents 
• New therapeutic approaches (bacteriophage, vaccine, etc.) 
• In vitro diagnostic device studies